• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Salix Pharmaceuticals Ltd. (SLXP)

    -NasdaqGS
    117.20 Down 1.25(1.06%) Dec 19, 4:00PM EST
    |After Hours : 117.20 Down 0.00 (0.00%) Dec 19, 6:58PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 933,838   735,444   540,488  
    Cost of Revenue179,392  124,597  95,369  
    Gross Profit 754,446   610,847   445,119  
    Operating Expenses
    Research Development149,974  123,234  104,350  
    Selling General and Administrative288,015  228,589  213,988  
    Non Recurring -  41,600   -  
    Others44,744  45,351  10,908  
    Total Operating Expenses -  438,774   -  
    Operating Income or Loss 271,713   172,073   115,873  
    Income from Continuing Operations
    Total Other Income/Expenses Net2,003  (4,727)2,349  
    Earnings Before Interest And Taxes273,716  167,346  118,222  
    Interest Expense61,651  55,518  32,121  
    Income Before Tax212,065  111,828  86,101  
    Income Tax Expense69,031  47,582  (1,298)
    Minority Interest -   -   -  
    Net Income From Continuing Ops143,034  48,666  87,399  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 143,034   64,246   87,399  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 143,034   64,246   87,399  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.